Of particular importance, the veterinary sales of antibiotics considered critically important in human medicine present a decreasing trend. Between 2011 and 2018, sales have reduced by:
- 24% for third and fourth generation cephalosporins;
- 70% for polymyxins;
- 4% for fluoroquinolones;
- 74% for other quinolones.
The situation across Europe remains contrasting. Out of the 25 countries that provided data covering 2011-2018, 18 countries observed a decline in sales of veterinary antibiotics overall sales have dropped by more than 5%. However, 5 countries recorded an increase of more than 5% and two other countries noted a minor decrease (below 2%) in overall sales.
The substantial decline in some countries indicate that there is also a potential for a decrease in other countries.